Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Monés JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Blumenkranz MS, et al. Among authors: vannier s. Arch Ophthalmol. 2002 Oct;120(10):1307-14. doi: 10.1001/archopht.120.10.1307. Arch Ophthalmol. 2002. PMID: 12365909 Clinical Trial.
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Bressler NM, Bressler SB, Haynes LA, Hao Y, Kaiser PK, Miller JW, Naor J, Potter MJ, Pournaras CJ, Reaves A, Rosenfeld PJ, Schmidt-Erfurth U, Slakter JS, Strong A, Vannier S. Bressler NM, et al. Among authors: vannier s. Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283. Arch Ophthalmol. 2005. PMID: 16157822 Clinical Trial. No abstract available.
Number of passes and outcome of endovascular treatment of anterior circulation large core ischemic stroke: insights from the Endovascular Treatment in Ischemic Stroke (ETIS) registry.
Lambrou V, Gory B, Lapergue B, Marnat G, Pop R, Calviere L, Anadani M, Blanc R, Finitsis SN; ETIS Study Group. Lambrou V, et al. J Neurointerv Surg. 2024 May 30:jnis-2024-021857. doi: 10.1136/jnis-2024-021857. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38816202
Mechanical thrombectomy in basilar artery occlusions: impact of first-line strategy as a function of the occlusion level.
Tournier L, Cortese J, Consoli A, Spelle L, Marnat G, Sarov M, Zhu F, Soize S, Burel J, Forestier G, Escalard S, Pop R, Bonnet B, Alias Q, Ognard J, Naggara O, Kyheng M, Lapergue B, Caroff J; ETIS Registry Investigators. Tournier L, et al. J Neurointerv Surg. 2024 Mar 27:jnis-2024-021491. doi: 10.1136/jnis-2024-021491. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38538055
Endovascular therapy of acute vertebrobasilar occlusions: influence of first-line strategy in the Endovascular Treatment in Ischemic Stroke (ETIS) Registry.
Bekri I, Finitsis S, Pizzuto S, Maier B, Piotin M, Eker OF, Marnat G, Sibon I, Dargazanli C, Bourcier R, Lapergue B, Pop R, Caroff J, Gory B, Pico F, Consoli A; ETIS Registry investigators. Bekri I, et al. J Neurointerv Surg. 2024 Feb 1:jnis-2023-021325. doi: 10.1136/jnis-2023-021325. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38302421
Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial.
Mazighi M, Köhrmann M, Lemmens R, Lyrer PA, Molina CA, Richard S, Toni D, Plétan Y, Sari A, Meilhoc A, Jandrot-Perrus M, Binay S, Avenard G, Comenducci A, Grouin JM, Grotta JC; ACTIMIS Study Group. Mazighi M, et al. Lancet Neurol. 2024 Feb;23(2):157-167. doi: 10.1016/S1474-4422(23)00427-1. Lancet Neurol. 2024. PMID: 38267188 Clinical Trial.
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG; PACIFIC-Stroke Steering Committee and Investigators. Smith EE, et al. Stroke. 2024 Feb;55(2):392-402. doi: 10.1161/STROKEAHA.123.043198. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174569 Clinical Trial.
Comparison of patients with biopsy positive and negative primary angiitis of the central nervous system.
Nehme A, Arquizan C, Régent A, Isabel C, Dequatre N, Guillon B, Capron J, Detante O, Lanthier S, Poppe AY, Boulouis G, Godard S, Terrier B, Pagnoux C, Aouba A, Touzé E, de Boysson H; Cohort of Patients with PACNS study group. Nehme A, et al. Rheumatology (Oxford). 2023 Oct 6:kead542. doi: 10.1093/rheumatology/kead542. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37802919
77 results